Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Osnabrück – page 3

57 clinical trials in Osnabrück, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Osnabrück at a glance
57
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

57 trials in Osnabrück

Open in trial search

Psoriasis

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Envudeucitinib
  • Sponsor:Alumis Inc.

Psoriasis

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Alumis Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nemolizumab
  • Sponsor:Galderma S.A.

Psoriasis

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Jnj-81241459
  • Sponsor:Janssen - Cilag International

Dermatitis atopic

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Dermatitis atopic

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Aluminium Hydroxide
  • Sponsor:HAL Allergy B.V.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Almirall S.A.
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Bilastine
  • Sponsor:Inmunotek S.L.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Dermatitis atopic

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:Levonorgestrel
  • Sponsor:Chemo Research S.L.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Osnabrück

What the registry says about research in the country

01 Dermatology Research

Extensive clinical trials focusing on moderate to severe plaque psoriasis and atopic dermatitis, evaluating new therapeutic approaches and long-term treatment options.

  • Psoriasis Studies
  • Atopic Dermatitis Management
  • Chronic Urticaria Treatment

Multiple studies examining novel biologics and targeted therapies for skin conditions.

02 Neurological Disorders

Research centered on epilepsy treatments, particularly investigating new medications for focal onset seizures and refractory cases.

  • Seizure Management
  • Status Epilepticus
  • Neurological Safety Studies

Innovative approaches to controlling seizures and improving patient outcomes.

03 Oncology Studies

Groundbreaking research in multiple myeloma and colon cancer, evaluating new treatment protocols and maintenance therapies.

  • Blood Cancer Treatments
  • Colorectal Cancer Research
  • Post-Transplantation Care

Focus on developing more effective and targeted cancer treatments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.